An Open-Label Study Evaluating Brexanolone in Adults With Tinnitus
Public ClinicalTrials.gov record NCT05645432. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
An Open-Label Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Efficacy of Brexanolone in the Treatment of Adult Participants With Tinnitus
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The primary objective of this study is to evaluate the safety and tolerability of brexanolone in participants with tinnitus following a single 6-hour continuous intravenous (IV) infusion.
Study identification
- NCT ID
- NCT05645432
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 10 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 65 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 9, 2023
- Primary completion
- Nov 20, 2023
- Completion
- Nov 20, 2023
- Last update posted
- Sep 14, 2025
2023
United States locations
- U.S. sites
- 2
- U.S. states
- 2
- U.S. cities
- 2
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Sage Investigational Site | Atlanta | Georgia | 30331 | — |
| Sage Investigational Site | Iowa City | Iowa | 52242 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Recently updated Tinnitus trials
Other public records listing Tinnitus. Sorted by last update posted; newest first. Not a recommendation.
- NCT07788638: Non-Invasive Neurofeedback Training to Alleviate Tinnitus Distress Recruiting
- NCT07158034: Investigating EEG as a Biomarker for Tinnitus Improvement After Bimodal Stimulation Active, not recruiting
- NCT03511807: Acoustic and Electrical Stimulation for the Treatment of Tinnitus Recruiting
- NCT07622407: Maximizing Quality of Life After Cancer Through Rehabilitation Not yet recruiting
- NCT04172766: Apple Hearing Study Active, not recruiting
- NCT07071480: Noninvasive Therapy for Tinnitus Recruiting
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05645432, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 14, 2025 · Synced Sep 1, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT05645432 live on ClinicalTrials.gov.